Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Molecular Therapy · 31 citations
https://doi.org/10.1016/j.ymthe.2023.03.020
T
Thomas Grothier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
81
Citations
4
h-index
3
i10-index
Thomas Grothier is an academic researcher. The author has contributed to research in topics: CAR-T cell therapy research & Nanowire Synthesis and Applications & Advancements in Semiconductor Devices and Circuit Design. The author has an h-index of 4, co-authored 30 publications.
ORCID: 0009-0003-0790-300XPapers by this author
worksData from Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.6750019.v3
Supplementary Figure S1-S26 from Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026774
Supplementary Figure S1-S26 from Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026774.v1
Supplementary Table 2 from Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026768.v1
Supplementary Table 2 from Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026768
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat